Lee, Danner & Bass’s Medtronic MDT Stock Holding History

Lee, Danner & Bass’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Buy	141,701 +20,283	+17%	+$1.64M	0.64%	39
2026 Q1	$10.5M	Buy	121,418 +8,365	+7%	+$801K	0.66%	40
2025 Q4	$10.9M	Sell	113,053 -2,737	-2%	-$266K	0.78%	31
2025 Q3	$11M	Sell	115,790 -5,666	-5%	-$521K	0.8%	31
2025 Q2	$10.6M	Buy	121,456 +758	+0.6%	+$64.3K	0.82%	30
2025 Q1	$10.8M	Sell	120,698 -1,757	-1%	-$157K	0.88%	29
2024 Q4	$9.78M	Sell	122,455 -3,465	-3%	-$300K	0.78%	32
2024 Q3	$11.3M	Sell	125,920 -2,996	-2%	-$252K	0.8%	27
2024 Q2	$10.1M	Buy	+128,916	New	+$10.6M	0.78%	29
2023 Q4	$10.3M	Sell	124,605 -11,174	-8%	-$852K	0.88%	27
2023 Q3	$10.6M	Sell	135,779 -975	-0.7%	-$81.6K	0.96%	22
2023 Q2	$12M	Buy	136,754 +3,155	+2%	+$272K	1.04%	19
2023 Q1	$10.8M	Sell	133,599 -2,925	-2%	-$238K	0.99%	25
2022 Q4	$10.6M	Buy	136,524 +13,510	+11%	+$1.09M	1%	25
2022 Q3	$9.93M	Buy	123,014 +6,108	+5%	+$549K	1.05%	22
2022 Q2	$10.5M	Buy	116,906 +18,490	+19%	+$1.87M	1.06%	22
2022 Q1	$10.9M	Buy	98,416 +4,844	+5%	+$512K	0.93%	26
2021 Q4	$9.68M	Buy	93,572 +27,505	+42%	+$3.19M	0.83%	31
2021 Q3	$8.28M	Buy	66,067 +330	+0.5%	+$42.7K	0.76%	35
2021 Q2	$8.16M	Buy	65,737 +2,758	+4%	+$346K	0.74%	38
2021 Q1	$7.44M	Hold	62,979	–	–	0.72%	40
2020 Q4	$7.38M	Buy	62,979 +2,325	+4%	+$256K	0.79%	34
2020 Q3	$6.3M	Sell	60,654 -1,800	-3%	-$181K	0.75%	36
2020 Q2	$5.73M	Buy	62,454 +4,785	+8%	+$459K	0.73%	37
2020 Q1	$5.2M	Buy	57,669 +195	+0.3%	+$20.7K	0.74%	39
2019 Q4	$6.52M	Sell	57,474 -173	-0.3%	-$19K	0.68%	39
2019 Q3	$6.26M	Sell	57,647 -276	-0.5%	-$28.8K	0.67%	41
2019 Q2	$5.64M	Sell	57,923 -2,121	-4%	-$194K	0.6%	45
2019 Q1	$5.47M	Sell	60,044 -303	-0.5%	-$27.1K	0.6%	46
2018 Q4	$5.49M	Buy	60,347 +611	+1%	+$57.1K	0.65%	45
2018 Q3	$5.88M	Sell	59,736 -1,906	-3%	-$176K	0.58%	46
2018 Q2	$5.28M	Sell	61,642 -123	-0.2%	-$10.3K	0.56%	46
2018 Q1	$4.96M	Buy	61,765 +4,346	+8%	+$358K	0.52%	51
2017 Q4	$4.64M	Sell	57,419 -949	-2%	-$76K	0.47%	56
2017 Q3	$4.54M	Buy	58,368 +2,397	+4%	+$199K	0.49%	53
2017 Q2	$4.97M	Sell	55,971 -200	-0.4%	-$16.9K	0.56%	49
2017 Q1	$4.53M	Sell	56,171 -1,754	-3%	-$137K	0.51%	49
2016 Q4	$4.13M	Buy	57,925 +693	+1%	+$54.4K	0.49%	52
2016 Q3	$4.95M	Sell	57,232 -809	-1%	-$70.5K	0.6%	46
2016 Q2	$5.04M	Buy	58,041 +3,053	+6%	+$247K	0.61%	44
2016 Q1	$4.33M	Buy	54,988 +1,858	+3%	+$140K	0.53%	48
2015 Q4	$4.09M	Sell	53,130 -2,632	-5%	-$198K	0.53%	49
2015 Q3	$3.73M	Sell	55,762 -7,168	-11%	-$528K	0.5%	51
2015 Q2	$4.66M	Sell	62,930 -614	-1%	-$46.9K	0.56%	46
2015 Q1	$4.96M	Buy	63,544 +2,166	+4%	+$164K	0.58%	44
2014 Q4	$4.43M	Buy	61,378 +46	+0.1%	+$3.19K	0.53%	48
2014 Q3	$3.8M	Sell	61,332 -183	-0.3%	-$11.6K	0.47%	51
2014 Q2	$3.92M	Sell	61,515 -569	-0.9%	-$34.6K	0.48%	51
2014 Q1	$3.82M	Sell	62,084 -323	-0.5%	-$18.8K	0.5%	51
2013 Q4	$3.58M	Sell	62,407 -2,555	-4%	-$145K	0.48%	49
2013 Q3	$3.46M	Sell	64,962 -1,948	-3%	-$105K	0.48%	48
2013 Q2	$3.44M	Buy	+66,910	New	+$3.31M	0.5%	49

Other funds holding MDT

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Lee, Danner & Bass's MDT Position: Q2 2026 in Review

Lee, Danner & Bass increased its Medtronic (MDT) stake by 17% in Q2 2026, buying an estimated $1.64M and bringing the position to 141,701 shares worth $11.1M. The position accounts for 0.64% of the portfolio, ranked #39.

Lee, Danner & Bass first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q2 2023. 823 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Lee, Danner & Bass held 141,701 shares of Medtronic worth $11.1M as of Q2 2026.
Lee, Danner & Bass bought 20,283 Medtronic shares in Q2 2026, an estimated $1.64M.
Medtronic made up 0.64% of Lee, Danner & Bass's portfolio in Q2 2026, its #39 holding.
Lee, Danner & Bass first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Lee, Danner & Bass's Medtronic position peaked at $12M in Q2 2023.
823 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.